Cyteir Therapeutics, President & CEO Donald F. Corcoran

Share this entry

Share on X
Share on WhatsApp

https://heritagepartners.com/wp-content/uploads/2016/03/HPI-Cyteir-Therapeutics-Donald-F.-Corcoran-Announcement.jpg 792 612 Ron Johnson https://heritagepartners.com/wp-content/uploads/2016/01/heritage_logo_color-transparent.png Ron Johnson2015-11-11 17:53:302016-03-02 18:01:54Cyteir Therapeutics, President & CEO Donald F. Corcoran

30736

Company News

Medicago Appoints Scot DeAthos as Executive Vice President, OperationsApril 24, 2021 - 1:38 am
Medicago Appoints Michael Morack as Chief Financial OfficerApril 24, 2021 - 1:37 am
Heritage Partners Places Chief Medical Officer for XentriaApril 15, 2021 - 1:24 am

Recent Placements

Medicago Appoints Scot DeAthos as Executive Vice President, OperationsApril 24, 2021 - 1:38 am
Medicago Appoints Michael Morack as Chief Financial OfficerApril 24, 2021 - 1:37 am
SiDx Appoints Dr. Caroline Popper to Board of DirectorsMay 18, 2020 - 3:42 pm

Find It Fast

Advantages
News
Contact Us
Partners

CAMBRIDGE, MA

COMPANY NEWS

Medicago Appoints Scot DeAthos as Executive Vice President, Operations April 24, 2021
Medicago Appoints Michael Morack as Chief Financial Officer April 24, 2021
Heritage Partners Places Chief Medical Officer for Xentria April 15, 2021

FIND IT FAST

Advantages
News
Contact Us
Partners

SEARCH

93571

LinkedIn

Privacy Policy

Bioclinica, SVP Global Sales, Steve Herne

Agilis Biotherapeutics, LLC, Chief Medical Officer, Chris Silber

Scroll to top